Abbott Laboratories (XSGO:ABT) Change In Payables And Accrued Expense : $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Abbott Laboratories Change In Payables And Accrued Expense?

Abbott Laboratories's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0 Mil. It means Abbott Laboratories's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Abbott Laboratories's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-760 Mil. It means Abbott Laboratories's Accounts Payable & Accrued Expense declined by $760 Mil from Dec. 2022 to Dec. 2023 .

Abbott Laboratories Change In Payables And Accrued Expense Historical Data

The historical data trend for Abbott Laboratories's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Change In Payables And Accrued Expense Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-325.00

1,152.00

1,288.00

420.00

-760.00

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Abbott Laboratories Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Abbott Laboratories Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (XSGO:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSGO:ABT) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.